These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7111067)

  • 21. Uremic toxins: new aspects.
    Hörl WH
    J Nephrol; 2000; 13 Suppl 3():S83-8. PubMed ID: 11132038
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Purine metabolites in uraemia.
    Simmonds HA; Cameron JS; Morris GS; Fairbanks LD; Davies PM
    Adv Exp Med Biol; 1987; 223():73-80. PubMed ID: 3447452
    [No Abstract]   [Full Text] [Related]  

  • 23. [Metabolic processes in the erythrocytes in disordered kidney function].
    Shepotinovskiĭ VI
    Urol Nefrol (Mosk); 1983; (3):62-6. PubMed ID: 6224339
    [No Abstract]   [Full Text] [Related]  

  • 24. Uremic toxins and platelet function.
    Horowitz HI
    Arch Intern Med; 1970 Nov; 126(5):823-6. PubMed ID: 5475705
    [No Abstract]   [Full Text] [Related]  

  • 25. Measurement of the apparent molecular volume of membrane-bound transport systems by radiation inactivation [proceedings].
    Ellory JC; Green JR; Jarvis SM; Young JD
    J Physiol; 1979 Oct; 295():10P-11P. PubMed ID: 521907
    [No Abstract]   [Full Text] [Related]  

  • 26. Uremic toxins, and their effect on intermediary metabolism.
    Wills MR
    Clin Chem; 1985 Jan; 31(1):5-13. PubMed ID: 3880681
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies on uremic toxins: the identification and the determination of toxic effect by tissue culture method.
    Yamada T; Hatano M; Tanaka T; Yoshida A; Takeuchi N
    Contrib Nephrol; 1977; 6():43-51. PubMed ID: 140039
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Harnessing transporters to clear uremic toxins.
    Moe OW
    J Am Soc Nephrol; 2009 Dec; 20(12):2483-4. PubMed ID: 19926890
    [No Abstract]   [Full Text] [Related]  

  • 29. An update on uremic toxins.
    Ringoir S
    Kidney Int Suppl; 1997 Nov; 62():S2-4. PubMed ID: 9350668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A bench to bedside view of uremic toxins.
    Vanholder R; Baurmeister U; Brunet P; Cohen G; Glorieux G; Jankowski J;
    J Am Soc Nephrol; 2008 May; 19(5):863-70. PubMed ID: 18287557
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urea movement across erythrocyte membrane during artificial kidney treatment.
    Cheung AK; Alford MF; Wilson MM; Leypoldt JK; Henderson LW
    Kidney Int; 1983 Jun; 23(6):866-9. PubMed ID: 6887697
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mass spectrometry in the search for uremic toxins.
    Niwa T
    Mass Spectrom Rev; 1997; 16(6):307-32. PubMed ID: 9703693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Separation, identification of uremic middle molecules, and preliminary study on their toxicity.
    Li G; Chu J; Liu X; Yuan Z
    Clin Chim Acta; 2004 Dec; 350(1-2):89-98. PubMed ID: 15530464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The role of dialysis membranes in elimination of uremic toxins].
    Grzeszczak W; Zukowska-Szczechowska E; Rutkowski B
    Przegl Lek; 1996; 53(5):439-42. PubMed ID: 8754410
    [No Abstract]   [Full Text] [Related]  

  • 35. Low water-soluble uremic toxins.
    Vanholder RC; Glorieux G; De Smet R; De Deyn PP
    Adv Ren Replace Ther; 2003 Oct; 10(4):257-69. PubMed ID: 14681857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Uraemic toxins.
    Dawborn JK
    Aust N Z J Med; 1981; 11(Suppl 1):40-5. PubMed ID: 6942801
    [No Abstract]   [Full Text] [Related]  

  • 37. Membrane and chromatography separation techniques for the preparative isolation of uremic toxins.
    Brunner H; Mann H
    Life Support Syst; 1983; 1 Suppl 1():199-206. PubMed ID: 6336410
    [No Abstract]   [Full Text] [Related]  

  • 38. New insights in uremic toxicity.
    Vanholder R; Glorieux G; Lameire GN
    Contrib Nephrol; 2005; 149():315-324. PubMed ID: 15876855
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Uremic toxins.
    Vanholder R
    Adv Nephrol Necker Hosp; 1997; 26():143-63. PubMed ID: 8922131
    [No Abstract]   [Full Text] [Related]  

  • 40. Potential role of middle molecular compounds in the development of uremic anemia.
    Leber HW; Debus E; Grulich U; Schütterle G
    Artif Organs; 1981; 4 Suppl():63-7. PubMed ID: 7295098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.